Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Special Drug-Use Surveillance of Entyvio in Ulcerative Colitis (Japan)
jRCT1080224534Completed
- Sponsor
- Takeda
- Start
- Jan 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of vedolizumab in autoimmune colitis, sponsored by Takeda. Primary endpoints: Safety of vedolizumab in routine clinical use and Effectiveness of vedolizumab in routine clinical use. Started Jan 2019; status: completed.
02
Drugs
vedolizumab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT1080224534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224534.